Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00429871 | Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer | completed | Phase 3 | 272 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2009 | clinicaltrials |
| NCT00909649 | Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy(MRM) | completed | N/A | 50 | Mansoura UniversityOTHER | 1 | May 28, 2009 |
| NCT00784862 | ATAC - Pharmacokinetics (PK) Sub-Protocol | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | May 15, 2009 | clinicaltrials |
| NCT00193908 | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream | completed | Phase 3 | 333 | Trans Tasman Radiation Oncology GroupOTHER | 1 | May 14, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00286117 | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | completed | Phase 3 | 448 | AstraZenecaINDUSTRY | 1 | May 1, 2009 | clinicaltrials |
| NCT00814125 | ATAC - Endometrial Sub-Protocol | completed | Phase 3 | 285 | AstraZenecaINDUSTRY | 0 | May 1, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00247481 | ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer | completed | Phase 2 | 77 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
| NCT00637026 | Ph II Early BC Pre-Surgical Biologic Study | completed | Phase 2 | 65 | AstraZenecaINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00632723 | IRESSA™ (Gefitinib) in Breast Cancer Patients | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 0 | Apr 22, 2009 | clinicaltrials |
| NCT00643513 | Quality Of Life While Receiving Faslodex | completed | — | 120 | AstraZenecaINDUSTRY | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00635713 | Second Line Breast Cancer Trial | completed | Phase 3 | 588 | AstraZenecaINDUSTRY | 0 | Apr 10, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00339248 | Markers for Breast Cancer | completed | — | 2,632 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2009 | clinicaltrials |
| NCT00043394 | CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer | completed | Phase 2 | 16 | PfizerINDUSTRY | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00200824 | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00859560 | Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg | completed | — | 2,205 | AstraZenecaINDUSTRY | 0 | Mar 11, 2009 | clinicaltrials |
| NCT00623519 | Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole | completed | — | 165 | AstraZenecaINDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00587925 | Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer | completed | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00299117 | Brief Smoking Intervention for Women Undergoing Breast Cancer Surgery | completed | N/A | 130 | Herlev HospitalOTHER | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00276211 | Diffusion Weighted MRI for Lymphnodes in the Axilla | completed | — | 10 | Copenhagen University Hospital at HerlevOTHER | 1 | Jan 28, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00809484 | Arimidex Bone Mass Index and Oral Bisphosphonates(ARBI) | completed | — | 220 | Hellenic Breast Surgeons SocietyOTHER | 1 | Jan 6, 2009 | clinicaltrials |
| NCT00548392 | Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement | completed | — | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 31, 2008 | clinicaltrials |
| NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 76 | NSABP Foundation IncNETWORK | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00188591 | Light Based Analysis of Developing Breast Tissue in Adolescent Girls: a Feasibility Study | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00198250 | Venlafaxine for Hot Flashes After Breast Cancer | completed | Phase 2 | 75 | Indiana UniversityOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00237354 | PV-10 Chemoablation of Recurrent Breast Carcinoma | completed | Phase 1 | 15 | Provectus PharmaceuticalsINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00777530 | Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects | completed | Phase 1 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Oct 23, 2008 | clinicaltrials |
| NCT00228930 | Tamoxifen Pharmacogenetics and Clinical Effects | completed | — | 297 | National Institute of General Medical Sciences (NIGMS)NIH | 1 | Sep 25, 2008 | clinicaltrials |
| NCT00328432 | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | completed | Phase 1 | 100 | University of KansasOTHER | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00291109 | An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg | completed | — | 40 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00291122 | An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer | completed | — | 100 | University of KansasOTHER | 1 | Sep 16, 2008 | clinicaltrials |
| NCT00594282 | Use of a Radiolucent Pad to Reduce Mammography Among African Americans | completed | N/A | 300 | University of KansasOTHER | 1 | Sep 12, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00387062 | Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | completed | Phase 1 | 50 | Posit Science CorporationINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | completed | Phase 2 | 100 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | completed | Phase 1 | 3 | University of MiamiOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00380952 | Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure | completed | N/A | 300 | Dune Medical DevicesINDUSTRY | 1 | May 28, 2008 | clinicaltrials |
| NCT00117910 | Treatment for Elderly Patients With High Risk Breast Cancer | completed | Phase 3 | — | AmgenINDUSTRY | 0 | May 16, 2008 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2009source: clinicaltrials